Intellia Therapeutics

BioTech/Drugs - Cambridge, MA, US

Intellia Therapeutics Employees
Eva Essig

Vice President, Regulatory Affairs and Quality

Contact Eva Essig

Ray Kelley

Vice President of Financial Planning Analysis

Contact Ray Kelley

Christine Foster

Senior Vice President Business Development

Contact Christine Foster

John Hayes

Vice President, Finance and Accounting

Contact John Hayes

Denny Truong

Senior Research Associate

Contact Denny Truong

View All Intellia Therapeutics Employees Contact All Intellia Therapeutics Employees
Intellia Therapeutics Senior Management
John Leonard

President and Chief Executive Officer

Contact John Leonard

Kathleen Shea

Sr. Executive Assistant to the CEO at Intellia Therapeutics

Contact Kathleen Shea

View All Intellia Therapeutics Employees Contact All Intellia Therapeutics Employees
Intellia Therapeutics Details

Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.We are focused on the development of proprietary therapeutics using a recently developed biological tool known as the CRISPR/Cas9 system. The promise of the CRISPR/Cas9 system is the driving force behind the creation of Intellia. Our founders have a shared belief that the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course. This technology offers the potential for us to develop curative therapeutic options for patients with chronic diseases by addressing the underlying cause of the disease. It can bring new hope and cures to people who now have nowhere to turn for help.Our combination of deep scientific expertise and clinical development experience, along with our leading intellectual property portfolio, puts Intellia in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. Intellia has the right people, assets and ambitious vision needed to take full advantage of the CRISPR/Cas9 technology's attributes – high potency, specificity, simplicity of use, broad applicability, and multifunctional programmability – and accelerate the advancement of curative products into the clinic.View our social media community guidelines at https://www.intelliatx.com/terms-and-conditions/ .

Intellia Therapeutics logo, Intellia Therapeutics contact details
Website: intelliatx.com
Employees: 500 - 999
HQ: 857-285-6200
Location: Cambridge, MA, US
Revenue: >1 Billion
B2C Biotechnology Cleantech Healthcare Medical Diagnostics Pharmaceuticals Wind Power Biotech BioTech/Drugs Commercial Physical Research Biotech Pharmaceuticals
Intellia Therapeutics Technologies
Email Providers

Mimecast

CMS

NetSuite

Domain Name Services

DNS Made Easy

Email Delivery

Rackspace MailGun

Other

Microsoft Office 365

View All Technologies Used At Intellia Therapeutics

Contacting Intellia Therapeutics: Connect with Executives and Employees

Get in Touch with Intellia Therapeutics Executives and Employees

Connecting with Intellia Therapeutics's Executives and Workforce

Accessing Contact Information for Intellia Therapeutics Executives

Connecting with Intellia Therapeutics: Reach Out to Their Team

Discover How to Contact Intellia Therapeutics Executives and Staff

Looking to connect with Intellia Therapeutics executives or employees?

Seeking to Get in Touch with Intellia Therapeutics Executives or Staff?

Want to Reach Out to Intellia Therapeutics Executives or Team Members?

In Search of Contact Details for Intellia Therapeutics Professionals?

Connecting with Intellia Therapeutics: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z